Waters (WAT) Given Daily News Impact Score of 0.05

Share on StockTwits

Press coverage about Waters (NYSE:WAT) has trended somewhat positive this week, according to Accern Sentiment. The research firm identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Waters earned a news sentiment score of 0.05 on Accern’s scale. Accern also gave news stories about the medical instruments supplier an impact score of 47.0277707288143 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

These are some of the news stories that may have effected Accern Sentiment Analysis’s scoring:

WAT has been the topic of a number of analyst reports. ValuEngine lowered Waters from a “buy” rating to a “hold” rating in a report on Wednesday, March 7th. Zacks Investment Research raised Waters from a “hold” rating to a “buy” rating and set a $239.00 price objective on the stock in a report on Monday, March 19th. Morgan Stanley lowered their price objective on Waters from $237.00 to $218.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 11th. Cowen reissued a “hold” rating and set a $215.00 price objective on shares of Waters in a report on Wednesday, April 25th. Finally, Leerink Swann set a $214.00 price objective on Waters and gave the company a “buy” rating in a report on Wednesday, April 25th. One analyst has rated the stock with a sell rating, twelve have given a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. Waters has an average rating of “Hold” and an average price target of $207.31.

WAT opened at $200.27 on Friday. The company has a market capitalization of $16.19 billion, a price-to-earnings ratio of 26.74, a price-to-earnings-growth ratio of 2.41 and a beta of 0.94. The company has a current ratio of 6.44, a quick ratio of 5.87 and a debt-to-equity ratio of 0.59. Waters has a 12-month low of $171.32 and a 12-month high of $220.20.

Waters (NYSE:WAT) last released its earnings results on Tuesday, April 24th. The medical instruments supplier reported $1.59 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.55 by $0.04. Waters had a return on equity of 25.80% and a net margin of 1.14%. The firm had revenue of $530.70 million for the quarter, compared to analyst estimates of $534.17 million. During the same quarter last year, the firm posted $1.46 EPS. The company’s revenue was up 6.6% on a year-over-year basis. research analysts expect that Waters will post 8.21 EPS for the current fiscal year.

Waters announced that its Board of Directors has authorized a stock buyback program on Tuesday, April 24th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the medical instruments supplier to buy up to 18.2% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s management believes its shares are undervalued.

In other news, Director Joann A. Reed sold 2,090 shares of Waters stock in a transaction that occurred on Tuesday, May 22nd. The stock was sold at an average price of $195.77, for a total transaction of $409,159.30. Following the sale, the director now owns 17,932 shares of the company’s stock, valued at approximately $3,510,547.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Michael F. Silveira sold 3,521 shares of Waters stock in a transaction that occurred on Thursday, May 17th. The stock was sold at an average price of $190.77, for a total value of $671,701.17. Following the sale, the vice president now directly owns 4,470 shares in the company, valued at approximately $852,741.90. The disclosure for this sale can be found here. Insiders have sold a total of 36,689 shares of company stock worth $7,130,365 in the last three months. 0.98% of the stock is owned by insiders.

About Waters

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Insider Buying and Selling by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Invesco Ltd.  Receives $39.55 Average PT from Brokerages
Invesco Ltd. Receives $39.55 Average PT from Brokerages
Zacks: Brokerages Anticipate VERONA PHARMA P/S  Will Announce Earnings of -$0.95 Per Share
Zacks: Brokerages Anticipate VERONA PHARMA P/S Will Announce Earnings of -$0.95 Per Share
Avalon Advisors LLC Buys Shares of 3,550 Xylem Inc
Avalon Advisors LLC Buys Shares of 3,550 Xylem Inc
Trillium Therapeutics Inc  Expected to Post Earnings of -$0.66 Per Share
Trillium Therapeutics Inc Expected to Post Earnings of -$0.66 Per Share
Xact Kapitalforvaltning AB Purchases Shares of 96,063 CBRE Group Inc
Xact Kapitalforvaltning AB Purchases Shares of 96,063 CBRE Group Inc
Moors & Cabot Inc. Has $4.26 Million Position in Honeywell
Moors & Cabot Inc. Has $4.26 Million Position in Honeywell


Leave a Reply

© 2006-2018 Ticker Report. Google+.